Capula Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Capula Management's AMGN Position: Q3 2026 in Review
Capula Management reduced its Amgen (AMGN) stake by 99% in Q3 2026, selling an estimated $119M and leaving 1,558 shares worth $657K. The position accounts for ﹤0.01% of the portfolio, ranked #559.
Capula Management first reported a position in AMGN in Q1 2021 and has held it in 18 quarters since. The position peaked at $109M in Q2 2026. 3,213 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- Capula Management held 1,558 shares of Amgen worth $657K as of Q3 2026.
- Capula Management sold 298,506 Amgen shares in Q3 2026, an estimated $119M.
- Amgen made up ﹤0.01% of Capula Management's portfolio in Q3 2026, its #559 holding.
- Capula Management first reported a position in Amgen in Q1 2021 and has held it in 18 quarters since.
- Capula Management's Amgen position peaked at $109M in Q2 2026.
- 3,213 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on Capula Management's 13F filing for Q3 2026, filed 16 Nov 2026.